Cargando…

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial

BACKGROUND: The De-ESCALaTE HPV trial confirmed the dominance of cisplatin over cetuximab for tumour control in patients with human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC). Here, we present the analysis of health-related quality of life (HRQoL), resource use, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, David A., Mistry, Pankaj, Dalby, Matthew, Fulton-Lieuw, Tessa, Kong, Anthony H., Dunn, Janet, Mehanna, Hisham M., Gray, Alastair M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Ltd 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947474/ https://www.ncbi.nlm.nih.gov/pubmed/31794928 http://dx.doi.org/10.1016/j.ejca.2019.10.025

Ejemplares similares

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
por: Mehanna, Hisham, et al.
Publicado: (2019)

Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV(+) “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Toxicity Reduction in the Treatment of HPV Positive Oropharyngeal Cancer: Emerging Combined Modality Approaches
por: Deschuymer, Sarah, et al.
Publicado: (2018)

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
por: Noronha, Vanita, et al.
Publicado: (2020)

The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies
por: Wierzbicka, Małgorzata, et al.
Publicado: (2015)

Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
por: Mirghani, Haitham, et al.
Publicado: (2017)

Impact of HPV in Oropharyngeal Cancer
por: Marklund, Linda, et al.
Publicado: (2011)

p16, HPV, and Cetuximab: What Is the Evidence?
por: Bonner, James A., et al.
Publicado: (2017)

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
por: Wurlitzer, Marcus, et al.
Publicado: (2020)

Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study
por: Mehanna, Hisham, et al.
Publicado: (2019)

Sensitive HPV detection in oropharyngeal cancers
por: Winder, David M, et al.
Publicado: (2009)

The immune response in HPV(+) oropharyngeal cancer
por: King, Emma V, et al.
Publicado: (2014)

Immunotherapy in HPV-Related Oropharyngeal Cancers
por: Roof, Logan, et al.
Publicado: (2023)

HPV-mediated oropharyngeal carcinogenesis: An overview
por: Patil†, Shankargouda
Publicado: (2022)

HPV+ Oropharyngeal Cancer in Waldenström Macroglobulinemia
por: Raslan, Shahm, et al.
Publicado: (2023)

What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials
por: Mensour, Emma A., et al.
Publicado: (2022)

Advances in the Management of HPV-Related Oropharyngeal Cancer
por: De Felice, F., et al.
Publicado: (2019)

Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma
por: Matlung, Sanne Evelien, et al.
Publicado: (2016)

Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study
por: Eisenberg, Marisa C, et al.
Publicado: (2018)

The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection—A Systematic Review
por: Nielsen, Kristoffer Juul, et al.
Publicado: (2021)

Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
por: Kanzow, Philipp, et al.
Publicado: (2023)

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins
por: Amini, Arya, et al.
Publicado: (2019)

Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV‐related oropharyngeal cancer and cancer of unknown primary
por: Tanaka, Hidenori, et al.
Publicado: (2021)

Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
por: Chera, Bhishamjit S., et al.
Publicado: (2020)

Knowledge of Human Papillomavirus (HPV) and Oropharyngeal Cancer and Acceptability of the HPV Vaccine among Dental Students
por: Farsi, Nada J, et al.
Publicado: (2020)

Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
por: Chitsike, Lennox, et al.
Publicado: (2021)

Does HPV type affect outcome in oropharyngeal cancer?
por: Nichols, Anthony C, et al.
Publicado: (2013)

HPV in oropharyngeal cancer: the basics to know in clinical practice
por: Elrefaey, S., et al.
Publicado: (2014)

Current perspectives on recurrent HPV-mediated oropharyngeal cancer
por: Guo, Theresa, et al.
Publicado: (2022)

Surgical clinical trials for HPV-positive oropharyngeal carcinoma
por: Lin, Chen, et al.
Publicado: (2022)

Whole genome sequencing reveals complexity in both HPV sequences present and HPV integrations in HPV-positive oropharyngeal squamous cell carcinomas
por: Gao, Ge, et al.
Publicado: (2019)

Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years
por: Haeggblom, Linnea, et al.
Publicado: (2017)

Cause‐specific mortality in HPV+ and HPV− oropharyngeal cancer patients: insights from a population‐based cohort
por: Nørregaard, Cecilie, et al.
Publicado: (2017)

The Role of HPV and Non-HPV Sexually Transmitted Infections in Patients with Oropharyngeal Carcinoma: A Case Control Study
por: Kofler, Barbara, et al.
Publicado: (2020)

Comparison of Selected Immune and Hematological Parameters and Their Impact on Survival in Patients with HPV-Related and HPV-Unrelated Oropharyngeal Cancer
por: Brewczyński, Adam, et al.
Publicado: (2021)

Determinants of the level of circulating-tumor HPV16 DNA in patients with HPV-associated oropharyngeal cancer at the time of diagnosis
por: Kentnowski, Marek, et al.
Publicado: (2023)

Detection of HPV related oropharyngeal cancer in oral rinse specimens
por: Rosenthal, Matthew, et al.
Publicado: (2017)

Irradiation of HPV-associated oropharyngeal cancer: Is less really more?
por: Mallory, Matthew, et al.
Publicado: (2017)

HPV in non-oropharyngeal head and neck cancer: does it matter?
por: Schmitt, Nicole C.
Publicado: (2020)

HPV vaccination disparities and strategies to prevent oropharyngeal cancer in males
por: Daniel, Casey L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7vck0dkl7uoml3hkf748an5rh7